{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T02:59:50Z","timestamp":1792724390170,"version":"4.5.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,5,16]],"date-time":"2018-05-16T00:00:00Z","timestamp":1526428800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,5,16]],"date-time":"2018-05-16T00:00:00Z","timestamp":1526428800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Neuromyelitis optica (NMO) is a rare autoimmune disease that affects the optic nerve and spinal cord. Most NMO patients (\u2009&gt;\u200970%) are seropositive for circulating autoantibodies against aquaporin 4 (NMO-IgG+). Here, we meta-analyze whole-genome sequences from 86 NMO cases and 460 controls with genome-wide SNP array from 129 NMO cases and 784 controls to test for association with SNPs and copy number variation (total\n                    <jats:italic>N<\/jats:italic>\n                    \u2009=\u2009215 NMO cases, 1244 controls). We identify two independent signals in the major histocompatibility complex (MHC) region associated with NMO-IgG+, one of which may be explained by structural variation in the complement component 4 genes. Mendelian Randomization analysis reveals a significant causal effect of known systemic lupus erythematosus (SLE), but not multiple sclerosis (MS), risk variants in NMO-IgG+. Our results suggest that genetic variants in the MHC region contribute to the etiology of NMO-IgG+ and that NMO-IgG+ is genetically more similar to SLE than MS.\n                  <\/jats:p>","DOI":"10.1038\/s41467-018-04332-3","type":"journal-article","created":{"date-parts":[[2018,5,10]],"date-time":"2018-05-10T04:51:00Z","timestamp":1525927860000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":134,"title":["A whole-genome sequence study identifies genetic risk factors for neuromyelitis optica"],"prefix":"10.1038","volume":"9","author":[{"given":"Karol","family":"Estrada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8446-8468","authenticated-orcid":false,"given":"Christopher W.","family":"Whelan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengmei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Bronson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3128-3547","authenticated-orcid":false,"given":"Robert E.","family":"Handsaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John P.","family":"Carulli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0175-6910","authenticated-orcid":false,"given":"Richard M.","family":"Ransohoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven A.","family":"McCarroll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron G.","family":"Day-Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin M.","family":"Greenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel G.","family":"MacArthur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,5,16]]},"reference":[{"key":"4332_CR1","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1155\/2006\/586306","volume":"22","author":"BG Weinshenker","year":"2006","unstructured":"Weinshenker, B. G., Wingerchuk, D. M., Pittock, S. J., Lucchinetti, C. F. & Lennon, V. A. NMO-IgG: a specific biomarker for neuromyelitis optica. Dis. Markers 22, 197\u2013206 (2006).","journal-title":"Dis. Markers"},{"key":"4332_CR2","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","volume":"364","author":"VA Lennon","year":"2004","unstructured":"Lennon, V. A. et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 364, 2106\u20132112 (2004).","journal-title":"Lancet"},{"key":"4332_CR3","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/S1474-4422(12)70133-3","volume":"11","author":"MC Papadopoulos","year":"2012","unstructured":"Papadopoulos, M. C. & Verkman, A. S. Aquaporin 4 and neuromyelitis optica. Lancet Neurol. 11, 535\u2013544 (2012).","journal-title":"Lancet Neurol."},{"key":"4332_CR4","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1073\/pnas.1119288109","volume":"109","author":"RM Ransohoff","year":"2012","unstructured":"Ransohoff, R. M. Illuminating neuromyelitis optica pathogenesis. Proc. Natl. Acad. Sci. USA 109, 1001\u20131002 (2012).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"4332_CR5","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.nbd.2009.10.013","volume":"37","author":"HJ Kim","year":"2010","unstructured":"Kim, H. J. et al. Common CYP7A1 promoter polymorphism associated with risk of neuromyelitis optica. Neurobiol. Dis. 37, 349\u2013355 (2010).","journal-title":"Neurobiol. Dis."},{"key":"4332_CR6","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1177\/1352458508102085","volume":"15","author":"H Zephir","year":"2009","unstructured":"Zephir, H. et al. Is neuromyelitis optica associated with human leukocyte antigen? Mult. Scler. 15, 571\u2013579 (2009).","journal-title":"Mult. Scler."},{"key":"4332_CR7","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1177\/1352458509350741","volume":"16","author":"DG Brum","year":"2010","unstructured":"Brum, D. G. et al. HLA-DRB association in neuromyelitis optica is different from that observed in multiple sclerosis. Mult. Scler. 16, 21\u201329 (2010).","journal-title":"Mult. Scler."},{"key":"4332_CR8","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1038\/ng.2770","volume":"45","author":"International Multiple Sclerosis Genetics, C.","year":"2013","unstructured":"International Multiple Sclerosis Genetics, C. et al. Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis. Nat. Genet. 45, 1353\u20131360 (2013).","journal-title":"Nat. Genet"},{"key":"4332_CR9","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/ng.768","volume":"43","author":"RE Handsaker","year":"2011","unstructured":"Handsaker, R. E., Korn, J. M., Nemesh, J. & McCarroll, S. A. Discovery and genotyping of genome structural polymorphism by sequencing on a population scale. Nat. Genet. 43, 269\u2013276 (2011).","journal-title":"Nat. Genet."},{"key":"4332_CR10","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/nature16549","volume":"530","author":"A Sekar","year":"2016","unstructured":"Sekar, A. et al. Schizophrenia risk from complex variation of complement component 4. Nature 530, 177\u2013183 (2016).","journal-title":"Nature"},{"key":"4332_CR11","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.jneuroim.2014.07.001","volume":"274","author":"P Nytrova","year":"2014","unstructured":"Nytrova, P. et al. Complement activation in patients with neuromyelitis optica. J. Neuroimmunol. 274, 185\u2013191 (2014).","journal-title":"J. Neuroimmunol."},{"key":"4332_CR12","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1086\/518257","volume":"80","author":"Y Yang","year":"2007","unstructured":"Yang, Y. et al. Gene copy-number variation and associated polymorphisms of complement component C4 in human systemic lupus erythematosus (SLE): low copy number is a risk factor for and high copy number is a protective factor against SLE susceptibility in European Americans. Am. J. Hum. Genet. 80, 1037\u20131054 (2007).","journal-title":"Am. J. Hum. Genet."},{"key":"4332_CR13","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.ajhg.2012.01.012","volume":"90","author":"L Boteva","year":"2012","unstructured":"Boteva, L. et al. Genetically determined partial complement C4 deficiency states are not independent risk factors for SLE in UK and Spanish populations. Am. J. Hum. Genet. 90, 445\u2013456 (2012).","journal-title":"Am. J. Hum. Genet."},{"key":"4332_CR14","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1038\/ng.3434","volume":"47","author":"J Bentham","year":"2015","unstructured":"Bentham, J. et al. Genetic association analyses implicate aberrant regulation of innate and adaptive immunity genes in the pathogenesis of systemic lupus erythematosus. Nat. Genet. 47, 1457\u20131464 (2015).","journal-title":"Nat. Genet."},{"key":"4332_CR15","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.molimm.2014.02.010","volume":"62","author":"BA Heesters","year":"2014","unstructured":"Heesters, B. A., Das, A., Chatterjee, P. & Carroll, M. C. Do follicular dendritic cells regulate lupus-specific B cells? Mol. Immunol. 62, 283\u2013288 (2014).","journal-title":"Mol. Immunol."},{"key":"4332_CR16","doi-asserted-by":"publisher","first-page":"e58712","DOI":"10.1371\/journal.pone.0058712","volume":"8","author":"D Basco","year":"2013","unstructured":"Basco, D. et al. AQP4-dependent water transport plays a functional role in exercise-induced skeletal muscle adaptations. PLoS ONE 8, e58712 (2013).","journal-title":"PLoS ONE"},{"key":"4332_CR17","first-page":"78","volume":"65","author":"SJ Pittock","year":"2008","unstructured":"Pittock, S. J. et al. Neuromyelitis optica and non organ-specific autoimmunity. Arch. Neurol. 65, 78\u201383 (2008).","journal-title":"Arch. Neurol."},{"key":"4332_CR18","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1016\/S0022-2836(02)00854-9","volume":"322","author":"JM van den Elsen","year":"2002","unstructured":"van den Elsen, J. M. et al. X-ray crystal structure of the C4d fragment of human complement component C4. J. Mol. Biol. 322, 1103\u20131115 (2002).","journal-title":"J. Mol. Biol."},{"key":"4332_CR19","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/379177a0","volume":"379","author":"AW Dodds","year":"1996","unstructured":"Dodds, A. W., Ren, X. D., Willis, A. C. & Law, S. K. The reaction mechanism of the internal thioester in the human complement component C4. Nature 379, 177\u2013179 (1996).","journal-title":"Nature"},{"key":"4332_CR20","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s00281-014-0424-x","volume":"36","author":"M Krumbholz","year":"2014","unstructured":"Krumbholz, M. & Meinl, E. B cells in MS and NMO: pathogenesis and therapy. Semin. Immunopathol. 36, 339\u2013350 (2014).","journal-title":"Semin. Immunopathol."},{"key":"4332_CR21","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1212\/01.wnl.0000216139.44259.74","volume":"66","author":"DM Wingerchuk","year":"2006","unstructured":"Wingerchuk, D. M., Lennon, V. A., Pittock, S. J., Lucchinetti, C. F. & Weinshenker, B. G. Revised diagnostic criteria for neuromyelitis optica. Neurology 66, 1485\u20131489 (2006).","journal-title":"Neurology"},{"key":"4332_CR22","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1002\/ajmg.b.32160","volume":"162B","author":"MT Pato","year":"2013","unstructured":"Pato, M. T. et al. The genomic psychiatry cohort: partners in discovery. Am. J. Med. Genet. B Neuropsychiatr. Genet. 162B, 306\u2013312 (2013).","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"4332_CR23","first-page":"11 10 1","volume":"43","author":"GA Van der Auwera","year":"2013","unstructured":"Van der Auwera, G. A. et al. From FastQ data to high confidence variant calls: the Genome Analysis Toolkit best practices pipeline. Curr. Protoc. Bioinformaics 43, 11.10.1\u201311.10.33 (2013).","journal-title":"Curr. Protoc. Bioinformaics"},{"key":"4332_CR24","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1101\/gr.107524.110","volume":"20","author":"A McKenna","year":"2010","unstructured":"McKenna, A. et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 20, 1297\u20131303 (2010).","journal-title":"Genome Res."},{"key":"4332_CR25","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/ng.806","volume":"43","author":"MA DePristo","year":"2011","unstructured":"DePristo, M. A. et al. A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat. Genet. 43, 491\u2013498 (2011).","journal-title":"Nat. Genet."},{"key":"4332_CR26","doi-asserted-by":"publisher","unstructured":"Poplin, R. et al. Scaling accurate genetic variant discovery to tens of thousands of samples. Preprint at\u00a0biorxiv: https:\/\/doi.org\/10.1101\/201178 (2017).","DOI":"10.1101\/201178"},{"key":"4332_CR27","doi-asserted-by":"publisher","first-page":"3118","DOI":"10.1093\/bioinformatics\/btu486","volume":"30","author":"EL Nicolazzi","year":"2014","unstructured":"Nicolazzi, E. L., Iamartino, D. & Williams, J. L. AffyPipe: an open-source pipeline for Affymetrix Axiom genotyping workflow. Bioinformatics 30, 3118\u20133119 (2014).","journal-title":"Bioinformatics"},{"key":"4332_CR28","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.ajhg.2015.11.020","volume":"98","author":"BL Browning","year":"2016","unstructured":"Browning, B. L. & Browning, S. R. Genotype Imputation with millions of reference samples. Am. J. Hum. Genet. 98, 116\u2013126 (2016).","journal-title":"Am. J. Hum. Genet."},{"key":"4332_CR29","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1038\/ng.3679","volume":"48","author":"PR Loh","year":"2016","unstructured":"Loh, P. R. et al. Reference-based phasing using the haplotype reference consortium panel. Nat. Genet. 48, 1443\u20131448 (2016).","journal-title":"Nat. Genet"},{"key":"4332_CR30","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.1093\/bioinformatics\/btq340","volume":"26","author":"CJ Willer","year":"2010","unstructured":"Willer, C. J., Li, Y. & Abecasis, G. R. METAL: fast and efficient meta-analysis of genomewide association scans. Bioinformatics 26, 2190\u20132191 (2010).","journal-title":"Bioinformatics"},{"key":"4332_CR31","doi-asserted-by":"publisher","first-page":"e64683","DOI":"10.1371\/journal.pone.0064683","volume":"8","author":"X Jia","year":"2013","unstructured":"Jia, X. et al. Imputing amino acid polymorphisms in human leukocyte antigens. PLoS ONE 8, e64683 (2013).","journal-title":"PLoS ONE"},{"key":"4332_CR32","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1038\/ng.3200","volume":"47","author":"RE Handsaker","year":"2015","unstructured":"Handsaker, R. E. et al. Large multiallelic copy number variations in humans. Nat. Genet. 47, 296\u2013303 (2015).","journal-title":"Nat. Genet."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-04332-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-04332-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-04332-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T09:02:05Z","timestamp":1671526925000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-04332-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,16]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["4332"],"URL":"https:\/\/doi.org\/10.1038\/s41467-018-04332-3","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,16]]},"assertion":[{"value":"12 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"K.E., P.B., C.S. are current Biogen employees. J.P.C., T.H. A.G.D.-W., and R.M.R. are former Biogen employees.\u00a0The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1929"}}